MedPath

Identification of Noninvasive Biomarkers for Neonates Undergoing Abdominal Surgery

Recruiting
Conditions
Neonate
Biomarkers
Interventions
Other: Biomarkers
Registration Number
NCT05181423
Lead Sponsor
West China Hospital
Brief Summary

To identify the potential serum and radiological biomarkers with regard to neonates undergoing abdominal surgery, and to further evaluate the prognostic value of these markers.

Detailed Description

First, the investigators will collect serum biomarkers in neonate patients receiving abdominal surgery. Then the investigators will identify the characteristics and change of biomarkers expressed in neonate patients before and after abdominal surgery. The investigators will further evaluate the prognostic value of these markers for neonate patients receiving abdominal surgery.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Age up to 18 years old
  • With written informed consent
Exclusion Criteria
  • Clinical data missing
  • Without written informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Retrospective cohortBiomarkersThe internal cohort was retrospectively enrolled in West China Hospital, Sichuan University from June 2010 and December 2020. It is a training and internal validation cohort.
Prospective cohortBiomarkersThe same inclusion/exclusion criteria were applied for the same center prospectively. It is a external validation cohort.
Primary Outcome Measures
NameTimeMethod
Value of non-invasive biomarkersAt least 5-year follow up

These markers will be collected in association with the prognostication for neonates before and after surgery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

West China Hospital, Sichuan University

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath